Sravnenie gemodinamicheskikh i biokhimicheskikh effektov karvedilola i atenolola i ikh vliyanie na prognoz u bol'nykh sakharnym diabetom 2 tipa, perenesshikh epizod nestabil'noy stenokardii

Sravnenie gemodinamicheskikh i biokhimicheskikh effektov karvedilola i atenolola i ikh vliyanie na prognoz u bol'nykh sakharnym diabetom 2 tipa, perenesshikh epizod nestabil'noy stenokardii

Цель. Сопоставить гемодинамические, биохими- ческие и прогностические эффекты карведилола и атенолола у больных СД 2, перенесших эпизод НС. Материалы и методы. В исследование включено 70 больных СД 2, осложнившимся НС. Во всех случаях диагностировались прогрессирующая стенокардия напряжения или впер...

Full description

Bibliographic Details
Main Authors:	L A Ivanova, S G Kanorskiy
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2008-06-01
Series:	Сахарный диабет
Subjects:	сахарный диабет 2 типа нестабильная стенокардия карведилол атенолол
Online Access:	https://www.dia-endojournals.ru/jour/article/view/5757

Similar Items

Otsenka prognosticheskoy znachimosti epizodov bezbolevoy ishemii miokarda i endotelial'noy disfunktsii pri nestabil'noy stenokardii
by: N. E Zakirova, et al.
Published: (2015-12-01)

Uroven' biomarkerov nekroza miokarda pri nestabil'noy stenokardii i ostrom infarkte miokarda u lits opasnykh professiy
by: N. N Zolotukhin, et al.
Published: (2017-03-01)

Osobennosti provedeniya fizicheskoy reabilitatsii pri ostrom infarkte miokarda i nestabil'noy stenokardii u lits opasnykh professiy
by: N. N Zolotukhin, et al.
Published: (2017-03-01)

Primenenie karvedilola u bol'nykh s metabolicheskim sindromom
by: V B Mychka, et al.
Published: (2005-06-01)

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015-09-01)

The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
by: V. V. Kalyuzhin, et al.
Published: (2002-03-01)

Place of the novel drug ranolazine in the treatment of coronary artery disease
by: GA Baryshnikova, et al.
Published: (2014-12-01)

Assessment of pleiotropic effects of nebivolol: influence on microcirculation parameters and bone tissue in postmenopausal women with mild arterial hypertension
by: I. L. Tepojan, et al.
Published: (2016-04-01)

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study
by: Kl. O. Stumpe, et al.
Published: (1970-01-01)

Sravnenie nefroprotektivnykh effektov selektivnogo blokatora endotelinovykh retseptorov i ingibitora APF na modeli eksperimental'nogo sakharnogo diabeta tipa 2
by: E Fedorova, et al.
Published: (2004-03-01)

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
by: R. D. Smith, et al.
Published: (2010-12-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

Beta-adrenoblokatory pri serdechnoy nedostatochnosti u bol'nykh sakharnym diabetom 2 tipa: karvedilol i risk gipoglikemiy
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2008-03-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
by: A. R. Kiselev, et al.
Published: (2016-01-01)

COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD)
by: Yu. V. Yu.V. Lukina, et al.
Published: (2016-01-01)

Carvedilol monotherapy and lifestyle modification among young patients with arterial hypertension and overweight/obesity in primary healthcare settings
by: G. I. Nechaeva, et al.
Published: (2010-12-01)

DETERMINATION OF THE IMPACT OF BISOPROLOL AND СARVEDILOL ON REGULATORY-ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAR FRACTION
by: V. G. Tregubov, et al.
Published: (2020-09-01)

Vozmozhnosti primeneniya beta-adrenoblokatorov s vazodilatiruyushchimi svoystvami u bol'nykh arterial'noy gipertoniey
by: N M Chikhladze, et al.
Published: (2004-06-01)

Antihypertensive therapy effectiveness in patients with arterial hypertension and varying risk of cardiovascular events
by: I. E. Chazova, et al.
Published: (2008-04-01)

Carvedilol therapy effects on structural and electric remodeling in chronic heart failure
by: E. V. Minakov, et al.
Published: (2008-02-01)

Thrombotic event prevention in patients with post-infarction chronic heart failure, as а part of complex therapy including various classes of beta -adrenoblockers
by: Yu. V. Larina, et al.
Published: (2008-12-01)

THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE
by: R. L. Dashnamirov
Published: (2014-04-01)

Carvedilol effectiveness in complex treatment of patients with arterial hypertension, coronary heart disease, and Type 2 diabetes mellitus
by: R. M. Shakirova, et al.
Published: (2007-10-01)

O dvije važne epizode riječkog antifuturizma i pseudofuturizma
by: Aljoša Pužar
Published: (2019-01-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Clinical and hemodynamic effects of carvedilol in patients with hypertrophic cardiomyopathy
by: T. A. Abdullaev, et al.
Published: (1970-01-01)

Clinical assessment of vasodilating carvedilol effects in patients with arterial hypertension and overweight/obesity: CAMELIA Study results
by: L. A. Sokolova, et al.
Published: (1970-01-01)

Sravnitel'naya otsenka antigipertenzivnogo i kardioprotektivnogo effektov lozartana i ego fiksirovannoy kombinatsii s gidrokhlortiazidom
by: L G Ratova, et al.
Published: (2004-06-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

SMOKING STATUS AND EFFECTIVENESS OF ANTIHYPERTENSIVE VASODILATING
by: O. V. Fedorishina, et al.
Published: (2013-02-01)

Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus
by: R. R. Samedov, et al.
Published: (2008-02-01)

Sravnenie effektivnosti dlitel'noy terapiilanreotidom i oktreotidom pri akromegalii
Published: (2006-09-01)

ChASTOTA POBOChNYKh EFFEKTOV DIKLOFENAKA I NAYZA U BOL'NYKh OSTEOARTROZOM
by: G G Bagirova, et al.
Published: (2005-06-01)

IZUChENIE PLEYOTROPNYKh EFFEKTOV V-ADRENOBLOKATOROV I INGIBITOROV APF NA KOSTNUYu TKAN'
by: I A SKRIPNIKOVA, et al.
Published: (2014-12-01)

Wrocławski epizod znanego stanisławowskiego księgarza i wydawcy Romana Jasielskiego i jego córki Anny
by: Rafał Werszler
Published: (2018-08-01)

EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
by: O. V. Fedorishina, et al.
Published: (2016-01-01)

Rol' metabolicheskikh i gemodinamicheskikh narusheniy u muzhchin s metabolicheskim sindromom v razvitii infertil'nosti i erektil'noy disfunktsii
Published: (2008-12-01)